- Raised $6.5M debt round led by Arc Impact, Mar 2024
- Raised $1M Series B led by eHealth Ventures, Dec 2021
- Raised $3.6M convertible note led by Merchavia Holdings, Dec 2021
About
EFA Technologies is an innovative Israeli MedTech company that is transforming point-of-care diagnostics by bringing laboratory-grade blood testing directly to patients. They develop, manufacture, and distribute RevDx™, a fully automated and portable CBC scanner that delivers rapid, accurate hematology results from a single drop of blood. The RevDx is a mobile end-point solution for performing automatic microscopy tests, including whole blood sampling and an automatic diagnosis of blood count. It is designed to be easy to operate, using a blood sample from a finger prick without the need for laboratory conditions or specific preparations, enabling users to make real-time informed decisions. The platform is also a disease-mapping solution for integrated community case management, aiming to automatically diagnose infectious diseases, starting with parasitology and blood cell count, to enable safe, precise, and affordable testing, treating, and tracking.
Funding history · 9 rounds · $12.6M total
Headcount over time
Q&A
- What is EFA Technologies' primary product?
- EFA Technologies develops RevDx, a portable, AI-based blood test diagnostic tool designed for real-time analysis of blood samples from a finger prick.
- When was EFA Technologies founded?
- EFA Technologies was founded in January 2016.
- What is the current employee count for EFA Technologies?
- EFA Technologies has 11-50 employees.
- What was the most recent funding round for EFA Technologies?
- In April 2024, EFA Technologies secured $6,500,000 in Debt Financing. Key investors included Maccabi Healthcare Services and Israel Innovation Authority
- What was the amount raised in EFA Technologies' 2024 Seed round?
- In 2024, EFA Technologies raised $6,500,000 in a Seed round with participation from existing investors and new partners, including eHealth Ventures.
- Which markets does EFA Technologies target with its products?
- EFA Technologies targets the Healthcare & Life Sciences sector, specifically Healthcare providers, with its diagnostic devices.
- What is the total amount of funding EFA Technologies has raised to date?
- EFA Technologies has raised a total of $12,590,000 USD.
- Has EFA Technologies expanded into the Brazilian market?
- Yes, in April 2024, EFA Technologies entered the Brazilian market following Anvisa approval of its portable RevDx device.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | efa-technologies.com |
|---|---|
| linkedin.com/company/35510797 | |
| YouTube | youtube.com/channel/UC6UCkBOyRRVRPiVJ923L1_A |
Identifiers & details
| Legal name | E.F.A. ENGINEERING FOR ALL LTD |
|---|---|
| Founded | 2016-1 |
| Employees (exact) | 17 |
| Offices | Bethesda |
Radar intelligence
Patents
| EPO | 133 |
|---|
Web history (Wayback)
| Domain | efa-technologies.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515337301 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-11-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — people (3), annual_report (2) |
| Registered address | הטוחן 17 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-23 | עדכון בעלי תפקידים |
| 2026-03-05 | דו~ח שנתי-הקצאת מניות |
| 2026-03-05 | דו~ח שנתי-הגדלת הון |
| 2026-02-04 | עדכון דירקטורים-הסרת דירקטור |
| 2026-02-04 | עדכון דירקטורים-הוספת דירקטור |